Today Boston Scientific announced it has entered into a definitive agreement to acquire Preventice Solutions, Inc.
The full press release can be found by visiting
The company’s primary investors include Boston Scientific, Merck Global Health Innovation Fund, Vivo Capital and Novo Holdings A/S.
About Preventice Solutions
Preventice Solutions is a leading developer of mobile health solutions and remote monitoring services that connect patients threatened by cardiac
arrhythmias. Using insights to create revolutionary monitoring technologies, this tech-enabled, service-based approach can ultimately reduce the
cost of care and improve health outcomes. Preventice Solutions’ wearable portfolio includes the PatientCare Platform and BodyGuardian ® family.